RAXTOZINAMERAN

UNII:	N36VHK46PR
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	RAXTOZINAMERAN
GSRS Full Record:	N36VHK46PR i

2887554-49-4
BNT162b2 Omicron (XBB.1.5)
RBP-020.2 4 (XBB.1.5 variant)
RNA (recombinant 5′-[1,2-[(3′-O-methyl)m7G-(5′→5′)-ppp-Am]]-capped all uridine→N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 spike glycoprotein secretory signal peptide plus codon-optimized pre-fusion spike glycoprotein omicron XBB.1.5 variant [982-proline,983-proline]-specifying plus 5′-and 3′-untranslated flanking region-containing poly(A)-tailed messengerRBP020.2 4), inner salt
Raxtozinameran
Raxtozinameran [WHO-DD]
messenger RNA (mRNA), 5'-capped, encoding a full-length, codon-optimised pre-fusion stabilised conformation variant (K982P and V983P) of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) spike (S) glycoprotein (Omicron sub-lineage XBB.1.5; based upon GISAID:EPI_ISL_17157779), flanked by 5' and 3' untranslated regions and a 3' polyadenylation (polyA) tail; contains N<sup>1</sup>-methylpseudouridine instead of uridine (all-U>m<sup>1</sup>Ψ)
raxtozinameran [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RAXTOZINAMERAN

Synonyms and Mappings

Resources